Financial incentives improve recognition but not treatment of cardiovascular risk factors in severe mental illness.

by Carol L Wilson, Kirsty M Rhodes, Rupert A Payne
Published 2017-01-01

Characteristics, service use and mortality of clusters of multimorbid patients in England: a population-based study

by Yajing Zhu, Duncan Edwards, Jonathan Mant, Rupert A. Payne, Steven Kiddle
Published 2020-04-01

Developing a measure of polypharmacy appropriateness in primary care: systematic review and expert consensus study

by Jenni Burt, Natasha Elmore, Stephen M. Campbell, Sarah Rodgers, Anthony J. Avery, Rupert A. Payne
Published 2018-06-01

Breaking bread: examining the impact of policy changes in access to state-funded provisions of gluten-free foods in England

by Myles-Jay Linton, Tim Jones, Amanda Owen-Smith, Rupert A. Payne, Joanna Coast, Joel Glynn, William Hollingworth
Published 2018-08-01

ACE inhibitor and angiotensin receptor-II antagonist prescribing and hospital admissions with acute kidney injury: a longitudinal ecological study.

by Laurie A Tomlinson, Gary A Abel, Afzal N Chaudhry, Charles R Tomson, Ian B Wilkinson, Martin O Roland, Rupert A Payne
Published 2013-01-01

Blood Pressure Changes Following Antihypertensive Medication Reduction, by Drug Class and Dose Chosen for Withdrawal: Exploratory Analysis of Data From the OPTiMISE Trial

by James P. Sheppard, Mark Lown, Jenni Burt, Gary A. Ford, F. D. Richard Hobbs, Paul Little, Jonathan Mant, Rupert A. Payne, Richard J. McManus, On behalf of the OPTiMISE Investigators
Published 2021-04-01

A multi-stakeholder approach to the co-production of the research agenda for medicines optimisation

by John Fellenor, Nicky Britten, Molly Courtenay, Rupert A. Payne, Jose Valderas, Rachel Denholm, Polly Duncan, Deborah McCahon, Lynn Tatnell, Richard Fitzgerald, Krystal Warmoth, David Gillespie, Katrina Turner, Margaret Watson
Published 2021-01-01